TipRanks
Go Ultimate55% OFF

Petros Pharmaceuticals (PTPI) Income Statement

Petros Pharmaceuticals Income Statement

Last quarter (Q2 2026), Petros Pharmaceuticals's total revenue was $0.00. In Q2, Petros Pharmaceuticals's net income was $-955.63K. See Petros Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Mar 22
$ 0.00$ 5.11M$ 5.82M$ 5.99M$ 7.81M
$ 0.00$ 3.90M$ 4.19M$ 3.70M$ 6.21M
$ 4.64M$ 21.58M$ 17.81M$ 23.62M$ 24.26M
Depreciation and Amortization$ 0.00$ 2.94M$ 3.42M$ 5.72M$ 6.88M
$ -4.50M$ -10.81M$ -4.21M$ -13.73M$ -1.74M
$ -4.64M$ -17.68M$ -13.62M$ -19.92M$ -18.05M
$ 141.31K$ 3.36M$ 5.45M$ -121.82K$ 9.06M
$ -4.50M$ -14.32M$ -8.16M$ -20.04M$ -8.99M
$ 1.91M$ -14.32M$ -8.16M$ -20.04M$ -8.99M
Per Share Metrics
Basic EPS$ -1.56$ -3.34$ -6.35$ -9.68$ -8.25
Diluted EPS$ -1.56$ -3.34$ -6.35$ -9.68$ -8.25
Weighted Average Shares Outstanding280.65M8.03M1.29M2.07M1.09M
Weighted Average Shares Outstanding (Diluted)280.65M8.03M2.18M2.07M1.09M

Currency in USD

Petros Pharmaceuticals Earnings and Revenue History

-40M-20M020M-400 %-300 %-200 %-100 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin